(Q43645159)

25 November 2017

title

The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation (English)

1 reference

25 November 2017

5

1 reference

25 November 2017

6

Edvinsson L

1 reference

25 November 2017

4

Jansen-Olesen I

1 reference

25 November 2017

Kruuse C

1

1 reference

25 November 2017

Rybalkin SD

series ordinal

2

1 reference

25 November 2017

Khurana TS

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

420

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

55-65

1 reference

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

HN-10200 causes endothelium-independent relaxations in isolated canine arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Nitric oxide and the cerebral circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Nitric oxide synthase inhibition and cerebrovascular regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Effects of the non-selective phosphodiesterase inhibitor pentoxifylline on regional cerebral blood flow and large arteries in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Dipyridamole Dilates Large Cerebral Arteries Concomitant to Headache Induction in Healthy Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

An in vitro Study of the Pharmacological Responses of Rat Middle Cerebral Artery: Effects of Overnight Storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Interaction of endothelium with dilation produced by inhibitors of cyclic nucleotide diesterases in mouse brain arterioles in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Nitric oxide/cAMP interactions in the control of rat renal vascular resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Cyclic GMP-phosphodiesterase inhibition does not alter cerebral oxygen consumption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

Phosphodiesterase Inhibitors: Their Comparative Effectiveness in Vitro in Various Organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901010-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01010-X

1 reference

25 November 2017

1 reference